Member Info for Sangijuelas1

Steph the stock is not trading on AIM. It's on the main market.

But yeah the 250 index funds will be offloading.

Could get ugly.

Selling is relentless

They announced that 10 months ago and still are nowhere near lending.

They have also had to delay publishing accounts for the 2nd year running.

Where do you get those rose tinted glasses?

We are priced at a quarter of NAV because the IPO market is closed for the foreseeable.

Don't be taken in by the ARM and Instacart scams that are only making 10% of their stock available so as to make short selling them harder.

What Graphcore are doing here with Mann is the same idea as Microsoft's research project with Barclays

https://www.graphcore.ai/posts/man-group-unlocks-massively-parallel-option-pricing-with-graphcore-ipu

Yeah but it's all still in the lab.

Whereas right now the IPU can run 9000 parallel processing threads at a lower energy cost than Nvidia chips

It's amusing how you pretend to be an expert on the semi conductor market.

I get the feeling the "research" you have done doesn't go very deep.

As for optical computing, by the time they make any meaningful progress, quantum computing will likely be in a stronger position.

Talking themselves up today as maybe opportunity opening for them to list given all the ARM and AI hype

https://www.google.com/amp/s/www.businessinsider.com/nvidia-gpus-chips-ai-commodity-graphcore-alternative-2023-9%3famp

T Rowe Price went below 5% in May. As a US entity they had no further need to report so I believe they have been selling out entirely.

They recently had something like 20bn dollars in fund withdrawals.

In an article from today's FT on SoftBank looking to make new investments, they apparently made a preliminary offer for Graphcore, although this was denied by the company.

Received a massive 40m dollar upfront payment from BioNTech who also took an equity stake in them.
Both companies in Cambridge with BioNTech building a new research centre for cancer vaccines in a collaboration with the UK government.
BioNTech already use tissue samples and have explored CtDNA to develop biomarkers for the vaccines. No reason why they wouldn't also be very interested in CTCs especially where the epithelial -mesenchymal transition comes into play. The head of Translational Sciences at BioNTech published a paper on EMT in breast cancer 5 years ago.
There's a reason why this is an RNS and not a Reach announcement. Because it is materially significant.

Late reported sell £665k showing as a buy.

Can tell it's a sell as a buy would have seen us go up today

Ledger might be leading the pack of the cold wallet companies but the concern is if Apple add cold wallet storage to one of their phones

MV participated
https://mobile.twitter.com/MoltenVentures/status/1641441399727063042

The Ledger raise is very disappointing in fact

It's about being realistic that this is an extremely risky investment. And Steph said all the core companies are fine. I disagree

I downloaded Aiven's atest annual report Companies House Finland,translated it and revenue was 37m Euros. Pretty much flat from the year before.
Their product is very complex, which makes it a hard sell. There was a convo a couple of months back with the CEO and the Datadog founder who is invested with them and it was all about how tough selling is. They recently laid off 20% of their staff and if you look at the 2 fundraises they had they burn a lot of cash.

Coachhub were beneficiaries of the extraordinary generosity of SoftBank. They also laid off 10% of their staff 2 months ago and the Glassdoor reviews describe a toxic work environment rife with bullying and idiotic management demands.

Ledger has just announced funding today, which I was going to post separately. They say the valuation was unchanged despite them previously looking for a higher one. They also haven't raised all of the 109m dollars they were looking for.
Not bad news but not great either
https://www.bnnbloomberg.ca/crypto-wallet-maker-ledger-locks-in-bulk-of-100-million-funding-round-1.1902552
https://www.bnnbloomberg.ca/crypto-wallet-maker-ledger-locks-in-bulk-of-100-million-funding-round-1.1902552

When this went to over £10 a share it's because there was a massive bubble post COVID.

The current NAV is a nonsense. There is no way our holding in Aiven is worth £127m. That business is lucky if the whole of it is worth £350m.

Steph, you do seem incredibly complacent here.

If any of the major holdings are in trouble we would not know about it until the administrators were called in.

A number have had substantial layoffs, which is a normal sign of trouble.

Revolut have had to have 2 loans recently to prop them up as they don't want a downround and the FT are making them out to be the next Wirecard.

I also have serious doubts about Aiven as they don't seem to be getting any traction in the market.

Lyst is on the rocks.
Coachhub is a piece of ****

If we lost Revolut, Coachhub and Aiven we would be wiped out.

We owe at least £90m and we have very little idea of the loan covenants as the pathetic UK regulators don't make companies publish them like they do in the US.

We do know that a big enough shock to NAV would call the loan ratio to assets into question and be a breach.

I have a feeling SBB UK had a holding and might be selling down since HSBC took over.

Think they were notified before and explains recent director buys

If you have a lot to sell you get a broker to sell large amounts throughout the day and then report after close.

I don't know what their motive is for selling but they do it under the radar to help with price stability and not spook market with large sells